Lutronic Corporation
Have updates for this profile? Please contribute data
= Subscriber Access Only
You are viewing a preview of this profile. Request a Preqin Pro demo for full access to all profiles and underlying data.
With Preqin Pro, you gain an unobstructed view of all alternative asset class activity across institutional investors, fund managers, funds, portfolio companies, deals, exits, and service providers.
Lutronic Corporation - overview
Established
1997
Location
Goyang, Gyeonggi, South Korea
Primary Industry
Medical Devices & Equipment
About
Lutronic Corporation, based in South Korea, specializes in developing advanced medical devices for aesthetic and dermatological treatments, focusing on laser systems and energy-based technologies that enhance skin rejuvenation and care. Founded in 1997, Lutronic Corporation operates in Goyang, South Korea, and is known for its innovative medical devices aimed at dermatological applications. The company was founded by Haelyung Hwang and has since made significant strides in the industry. Lutronic's most recent round of funding was a Public to Private transaction on June 8, 2023, where Hahn & Company invested KRW 188.
9 billion, bringing the total amount raised to KRW 964. 6 billion. Lutronic specializes in advanced medical devices designed for aesthetic and dermatological applications. The company's core product offerings include sophisticated laser systems and other energy-based technologies that facilitate skin rejuvenation, scar reduction, and hair removal.
These products address various skin concerns such as pigmentation issues, acne scars, and signs of aging, appealing to medical professionals and patients alike. With a focus on precision and efficacy, Lutronic's devices are utilized in clinics and dermatology practices across diverse geographical markets, including North America, Europe, and parts of Asia. Lutronic generated revenue of KRW 134,640,618. 6 in the most recent year 2024.
The company benefits from a business model that includes direct sales and service agreements for its medical devices, with additional revenue stemming from ongoing maintenance and support services. This ensures optimal performance and customer satisfaction, with pricing structures reflecting the advanced technology of their flagship products. Lutronic plans to leverage its recent funding of KRW 188. 9 billion to support the launch of new products and expand into new markets.
Upcoming product designs are aimed at enhancing their existing laser systems, with specific release dates yet to be announced. Geographically, Lutronic is targeting expansion into additional regions in Europe and Asia by 2025, further solidifying its international presence in the dermatological device market.
Current Investors
Hahn & Company, Cynosure LLC / Lutronic Corporation
Primary Industry
Medical Devices & Equipment
Sub Industries
Medical Equipment Distributors
Website
https://kr.lutronic.com
Verticals
Manufacturing
Company Stage
Merged
Total Amount Raised
Subscriber access only
Lutronic Corporation - deals
| Deals Type | Deal Status | Target (s) | Deal Date | Investor(s) | Seller(s) | Deal size (Mn) | Enterprise value (Mn) | Post-money valuation (Mn) | EBITDA multiple (x) | Revenue multiple (x) | Lead partner (s) |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Merger | Completed | Cynosure LLC, Lutronic Corporation | - | ||||||||
| Public to Private | Completed | Lutronic Corporation | - | ||||||||
| PIPE | Completed | Lutronic Corporation | - |
Displaying 1 - 3 of 3
Time to go Pro
Get Preqin Pro for unrestricted access to 600,000+ detailed profiles on fund managers, investors, funds, companies, and other alternative asset players. Unlock exclusive data on future plans, company financials, fundraising history, track records, and more.